Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease

被引:0
|
作者
Terai, K [1 ]
Matsuo, A [1 ]
McGeer, PL [1 ]
机构
[1] UNIV BRITISH COLUMBIA,KINSMEN LAB NEUROL RES,VANCOUVER,BC V6T 1Z3,CANADA
关键词
immunohistochemistry; nuclear factor-kappa B; Alzheimer's disease; human brain; neuron; hippocampal formation; cerebral cortex;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The distribution of nuclear factor-kappa B (NF-kappa B) was investigated immunohistochemically in the hippocampal formation, entorhinal cortex, middle temporal gyrus and visual cortex of Alzheimer's disease (AD) and control postmortem cases using a polyclonal antibody against the NF-kappa B p65 subunit. In AD cases, prominent staining for NF-kappa B was seen in neurons and their processes, neurofibrillary tangles and dystrophic neurites. In control cases, only weak staining of some neurons was obtained. The neuronal staining observed in AD was strongest in the hippocampal formation and entorhinal cortex, less in the middle temporal gyrus and least in the visual cortex. There was no difference between AD and control cases in the staining of glial cells and vascular walls. These results suggest that enhanced expression of neuronal NF-kappa B occurs in areas affected by AD pathology.
引用
收藏
页码:159 / 168
页数:10
相关论文
共 50 条
  • [1] Enhancement of immunoreactivity for NF-kappa B in human cerebral infarctions
    Terai, K
    Matsuo, A
    McGeer, EG
    McGeer, PL
    BRAIN RESEARCH, 1996, 739 (1-2) : 343 - 349
  • [2] Nuclear translocation of NF-kappa B in cholinergic neurons of patients with Alzheimer's disease
    Boissiere, F
    Hunot, S
    Faucheux, B
    Duyckaerts, C
    Hauw, JJ
    Agid, Y
    Hirsch, EC
    NEUROREPORT, 1997, 8 (13) : 2849 - 2852
  • [3] Alteration of transcription factors NF-kappa B and STAT1 in Alzheimer's disease brains
    Kitamura, Y
    Shimohama, S
    Ota, T
    Matsuoka, Y
    Nomura, Y
    Taniguchi, T
    NEUROSCIENCE LETTERS, 1997, 237 (01) : 17 - 20
  • [4] NF-kappa B activation correlates with disease phenotype in Crohn's disease
    Han, Yoo Min
    Koh, Jaemoon
    Kim, Ji Won
    Lee, Changhyun
    Koh, Seong-Joon
    Kim, ByeongGwan
    Lee, Kook Lae
    Im, Jong Pil
    Kim, Joo Sung
    PLOS ONE, 2017, 12 (07):
  • [5] The Effects of NF-kappa B Inhibitors on Bone Formation
    Aoki, Kazuhiro
    JOURNAL OF ORAL BIOSCIENCES, 2010, 52 (04) : 303 - 310
  • [6] NF-kappa B p65 immunoreactivity is induced in astroglial cells in hippocampal zone susceptible to degeneration after transient global cerebral ischemia in rats
    Oderfeld-Nowak, B
    Orzylowska, O
    Kaminska, B
    Zaremba, M
    Januszewski, S
    Mossakowski, M
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 : S64 - S64
  • [7] Hippocampal plasticity in Alzheimer's disease: changes in highly polysialylated NCAM immunoreactivity in the hippocampal formation
    Mikkonen, M
    Soininen, H
    Tapiola, T
    Alafuzoff, I
    Miettinen, R
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1999, 11 (05) : 1754 - 1764
  • [8] Regulation of NF-kappa B and disease control: Identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-kappa B activation
    Okamoto, T
    Sakurada, S
    Yang, JP
    Merin, JP
    CURRENT TOPICS IN CELLULAR REGULATION, VOL 35, 1997, 35 : 149 - 161
  • [9] Peptide therapy inhibiting NF-kappa B may prevent Parkinson's disease progression
    Ghosh, A.
    Roy, A.
    Liu, X.
    FUTURE NEUROLOGY, 2008, 3 (01) : 7 - 7
  • [10] Serological Analysis of Alpha-synuclein and NF-kappa B in Parkinson's Disease Patients
    Gupta, Vineeta
    Garg, Ravindra Kumar
    Khattri, Sanjay
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (05) : BC1 - BC4